Zephyrus I: Evaluation of Efficacy and Safety of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
No overall officials are registered on this study record. Site-level investigators, where published, appear with their sites below. Why? →
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
125 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Centro de Investigacion Metabolica 'Cinme'
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Consultorios Medicos. Organización del Buen Ayre. Srl
Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina
- Fundacion Respirar - Centro Médico Dra. de Salvo
Ciudad Autonoma de Buenos Aires (caba), Buenos Aires, Argentina
- Centro Medico de Enfermedades Respiratorias
Florida, Buenos Aires, Argentina
- Centro Platense En Investigaciones Respiratorias
La Plata, Buenos Aires, Argentina
- Instituto Ave Pulmo Fundacion Enfisema
Mar del Plata, Buenos Aires, Argentina
- Respira Salud Clinica Integral
Godoy Cruz, Mendoza Province, Argentina
- Insares
Mendoza, Mendoza Province, Argentina
- Investigaciones En Patologias Respiratorias
San Miguel de Tucumán, Tucumán Province, Argentina
- Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
- Westmead Hospital
Westmead, New South Wales, Australia
- Mater Health Services Adult Hospital
South Brisbane, Queensland, Australia
- Royal Adelaide Hospital
Adelaide, South Australia, Australia
- Box Hill Hospital
Box Hill, Victoria, Australia
- the Alfred Hospital
Melbourne, Victoria, Australia
- Centro Investigacion del Maule Cim
Talca, Maule Region, Chile
- Cimer
Santiago, Santiago Metropolitan, Chile
- Instituto Nacional del Torax
Santiago, Santiago Metropolitan, Chile
- M Y F Estudios Clinicos
Santiago, Santiago Metropolitan, Chile
- Second Affiliated Hospital of Anhui Medical University
Hefei, Anhui, China
- Beijing Chao-Yang Hospital,capital Medical University
Beijing, Beijing Municipality, China
- China-Japan Friendship Hospital
Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital
Beijing, Beijing Municipality, China
- Nanfang Hospital of Southern Medical University
Guangzhou, Guangdong, China
- the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China
- Shenzhen People'S Hospital
Shenzhen, Guangdong, China
- Henan Provincial People'S Hospital
Zhengzhou, Henan, China
- Henan Provincial Chest Hospital
Zhengzhou, Henan, China
- Tongji Hospital, Tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
- Union Hospital，tongji Medical College of Huazhong University of Science and Technology
Wuhan, Hubei, China
- the Second Xiangya Hospital of Central South University
Changsha, Hunan, China
- Affiliated Hospital of Inner Mongolia Medical University
Hohhot, Inner Mongolia, China
- People'S Hospital of Inner Mongolia Autonomous Region
Hohhot, Inner Mongolia, China
- the Second Hospital of Dalian Medical University
Dalian, Liaoning, China
- the First Hospital of China Medical University
Shenyang, Liaoning, China
- General Hospital of Ningxia Medical University
Yinchuan, Ningxia, China
- Ruijin Hospital Affiliated To Shanghai Jiao Tong University School of Medicine
Shanghai, Shanghai Municipality, China
- the Second Affiliated Hospital of Xi'An Jiaotong University
Xi’an, Shanxi, China
- Huaxi Hospital of Sichuan University.
Chengdu, Sichuan, China
- General Hospital of Tianjin Medical University
Tianjin, Tianjin Municipality, China
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 18 Jun 2019
- Primary completion
- 20 Mar 2023
- Completion
- 28 Aug 2023
- Last update posted
- 19 Sept 2024
- Registered enrollment
- 393
- Registry id
- NCT03955146
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.